Chapter 11. Subependymal Giant Cell Astrocytomas

  1. Dr. David J. Kwiatkowski3,
  2. Dr. Vicky Holets Whittemore4 and
  3. Dr. Elizabeth A. Thiele5
  1. David Neal Franz1,
  2. Darcy A. Krueger1 and
  3. M. Gregory Balko2

Published Online: 9 JUN 2010

DOI: 10.1002/9783527630073.ch11

Tuberous Sclerosis Complex: Genes, Clinical Features and Therapeutics

Tuberous Sclerosis Complex: Genes, Clinical Features and Therapeutics

How to Cite

Franz, D. N., Krueger, D. A. and Balko, M. G. (2010) Subependymal Giant Cell Astrocytomas, in Tuberous Sclerosis Complex: Genes, Clinical Features and Therapeutics (eds D. J. Kwiatkowski, V. H. Whittemore and E. A. Thiele), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany. doi: 10.1002/9783527630073.ch11

Editor Information

  1. 3

    Brigham & Women's Hospital, Dana Farber Cancer Institute, Harvard Medical School, 1 Blackfan Circle, Boston, MA 02115, USA

  2. 4

    Tuberous Sclerosis Alliance, 801 Roeder Road, Silver Spring, MD 20910, USA

  3. 5

    Carol & James Herscot Center For TCS, Massachusetts General Hospital, Department of Neurology, 175 Cambridge Street, Boston, MA 02114, USA

Author Information

  1. 1

    University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA

  2. 2

    Wright State University Boonshoft School of Medicine, Dayton, OH, USA

Publication History

  1. Published Online: 9 JUN 2010
  2. Published Print: 21 APR 2010

ISBN Information

Print ISBN: 9783527322015

Online ISBN: 9783527630073

SEARCH

Keywords:

  • giant cell;
  • obstructive hydrocephalus;
  • rapamycin;
  • SEGAs;
  • subependymal nodule;
  • tuberous sclerosis complex

Summary

This chapter contains sections titled:

  • Introduction

  • Pathology and Pathogenesis of SEGA

  • SENs Versus SEGAs

  • Diagnosis of SEGA Versus SEN

  • Current Management of SEGASs

  • Medical Management of SEGAs

  • Conclusion and Summary

  • References